Caraceni, Paolo

Publishing since 1992 (Senior)

Has published 68 publications in 18 years

Number of publications published per year by Caraceni, Paolo. (Source : PubMed)

Distribution of publications types for Caraceni, Paolo. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

Domenicali M, Caraceni P, Giannone F, Baldassarre M, Lucchetti G, Quarta C, Patti C, Catani L, Nanni C, Lemoli RM, Bernardi M. A novel model of CCl4-induced cirrhosis with ascites in the mouse. J. Hepatol. 2009;51;6
Caraceni P, Viola A, Piscitelli F, Giannone F, Berzigotti A, Cescon M, Domenicali M, Petrosino S, Giampalma E, Riili A, Grazi G, Golfieri R, Zoli M, Bernardi M, Di Marzo V. Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis. Liver Int. 2009
Caraceni P, Pertosa AM, Giannone F, Domenicali M, Grattagliano I, Principe A, Mastroleo C, Perrelli MG, Cutrin J, Trevisani F, Croci T, Bernardi M. Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischaemia-reperfusion injury complicated by endotoxaemia. Gut 2009;58;8
Domenicali M, Caraceni P, Giannone F, Pertosa AM, Principe A, Zambruni A, Trevisani F, Croci T, Bernardi M. Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis. Gastroenterology 2009;137;1
Cescon M, Carini R, Grazi G, Caraceni P, Alchera E, Gasloli G, Ravaioli M, Tuci F, Imarisio C, Dal Ponte C, Pertosa AM, Bernardi M, Pinna AD, Albano E. Variable activation of phosphoinositide 3-kinase influences the response of liver grafts to ischemic preconditioning. J. Hepatol. 2009;50;5
Caraceni P, Domenicali M, Giannone F, Bernardi M. The role of the endocannabinoid system in liver diseases. Best Pract. Res. Clin. Endocrinol. Metab. 2009;23;1
Caraceni P, Dazzani F, Salizzoni E, Domenicali M, Zambruni A, Trevisani F, Bernardi M. Muscle circulation contributes to hyperdynamic circulatory syndrome in advanced cirrhosis. J. Hepatol. 2008;48;4
Zambruni A, Trevisani F, Di Micoli A, Savelli F, Berzigotti A, Bracci E, Caraceni P, Domenicali M, Felline P, Zoli M, Bernardi M. Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis. J. Hepatol. 2008;48;3
Caraceni P, Giannone F, Catani L, Talarico S, Pertosa AM, Domenicali M, Fogli M, Principe A, Trevisani F, Baccarani M, Bernardi M, Lemoli RM. Effects of granulocyte colony stimulating-factor in a rat model of acute liver injury. Dig Liver Dis 2007;39;10
Golfieri R, Coppola F, Fusco F, Li Bassi S, Caraceni P, Bernardi M, Trevisani F. Malignant progression of a small HCC nodule: hypovascular 'early HCC' converted to hypervascular 'small HCC' within six months. Dig Liver Dis 2007;39;9

[ See timeline ] [ See all publications ]

h=23

means that Caraceni, Paolo has 23 papers cited a least 23 times - methodology

Key figures

68 pub in 18 years
3.8 publications/year
best year 1994 with 12 pub
h-index 23 with 68 pub
h-ratio : 33 %

See Timeline

Ranking

It's me !

Click here if you are
Caraceni, Paolo.

Most frequent Journals

J. Hepatol. (16x)
Transplant. Proc. (13x)
Dig Liver Dis (6x)
Hepatology (5x)
Hepatogastroenterology (4x)

Main affiliation

Department of General Surgery and Organ Transplantation, Liver and Multiorgan Transplant Unit, Alma Mater Studiorum University of Bologna, Bologna, Italy.

Latest co-workers

Angiolini G Beltempo P Bernardi M Bertelli R Cavallari A Cavallari G Chieco P Domenicali M Giannone F Grattagliano I Nardo B Neri F Pacilè V Pariali M Pertosa AM Principe A Puviani L Trevisani F Tsivian M Zambruni A

Back to HepaTop

Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.